Skip to main navigation Skip to search Skip to main content

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)

  • Se Hyun Kim
  • , Seock Ah Im
  • , Koung Jin Suh
  • , Kyung Hun Lee
  • , Min Hwan Kim
  • , Joohyuk Sohn
  • , Yeon Hee Park
  • , Ji Yeon Kim
  • , Jae Ho Jeong
  • , Kyoung Eun Lee
  • , In Sil Choi
  • , Kyong Hwa Park
  • , Hee Jun Kim
  • , Eun Kyung Cho
  • , So Yeon Park
  • , Milim Kim
  • , Jee Hyun Kim

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science